CEU-San Pablo University and HM-Hospitals School Medicine
Fernando Vidal-Vanaclocha is full professor and chair of the PhD program in Translational Medicine and the Master degree in Regenerative Medicine and Cell Therapies, at the CEU-San Pablo University and HM-Hospitals School Medicine, Madrid. As a medical doctor with PhD training in Pathology, he has been involved in cancer metastasis research over more than 30 years. By taking advantage of his position as Chief Scientific Officer at HM-Hospitals, in 2010 he founded the Institute for Applied Molecular Medicine (IMMA). He is also adjunct Professor of Molecular Medicine, George Washington Univ. Sch. Med., Washington-DC and Editor of the Cancer Microenvironment Section, Journal Translational Medicine.